Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the secondary prevention of cardiovascular disease: forecasting the incremental benefits of preventing coronary and cerebrovascular events.
Grover SA, Coupal L, Paquet S, Zowall H. Grover SA, et al. Among authors: zowall h. Arch Intern Med. 1999 Mar 22;159(6):593-600. doi: 10.1001/archinte.159.6.593. Arch Intern Med. 1999. PMID: 10090116
The cost-effectiveness of highly active antiretroviral therapy, Canada 1991-2001.
Beck EJ, Mandalia S, Gaudreault M, Brewer C, Zowall H, Gilmore N, Klein MB, Lalonde R, Piché A, Hankins CA. Beck EJ, et al. Among authors: zowall h. AIDS. 2004 Dec 3;18(18):2411-8. AIDS. 2004. PMID: 15622317
Cost-effectiveness of lipid-lowering treatment according to lipid level.
Pilote L, Ho V, Lavoie F, Coupal L, Zowall H, Grover SA. Pilote L, et al. Among authors: zowall h. Can J Cardiol. 2005 Jun;21(8):681-7. Can J Cardiol. 2005. PMID: 16003451
Costs of dyslipidemia.
Zowall H, Grover SA. Zowall H, et al. Expert Rev Pharmacoecon Outcomes Res. 2003 Jun;3(3):273-81. doi: 10.1586/14737167.3.3.273. Expert Rev Pharmacoecon Outcomes Res. 2003. PMID: 19807375
Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization?
Grover SA, Coupal L, Zowall H. Grover SA, et al. Among authors: zowall h. Hypertension. 2005 Jan;45(1):92-7. doi: 10.1161/01.HYP.0000149684.01903.b8. Epub 2004 Nov 15. Hypertension. 2005. PMID: 15545508
The importance of indirect costs in primary cardiovascular disease prevention: can we save lives and money with statins?
Grover SA, Ho V, Lavoie F, Coupal L, Zowall H, Pilote L. Grover SA, et al. Among authors: zowall h. Arch Intern Med. 2003 Feb 10;163(3):333-9. doi: 10.1001/archinte.163.3.333. Arch Intern Med. 2003. PMID: 12578514
Evaluating the benefits of treating dyslipidemia: the importance of diabetes as a risk factor.
Grover SA, Coupal L, Zowall H, Weiss TW, Alexander CM. Grover SA, et al. Among authors: zowall h. Am J Med. 2003 Aug 1;115(2):122-8. doi: 10.1016/s0002-9343(03)00303-6. Am J Med. 2003. PMID: 12893398
Cost-effectiveness of treating hyperlipidemia in the presence of diabetes : who should be treated?
Grover SA, Coupal L, Zowall H, Dorais M. Grover SA, et al. Among authors: zowall h. Circulation. 2000 Aug 15;102(7):722-7. doi: 10.1161/01.cir.102.7.722. Circulation. 2000. PMID: 10942738
The cost-effectiveness of exercise training for the primary and secondary prevention of cardiovascular disease.
Lowensteyn I, Coupal L, Zowall H, Grover SA. Lowensteyn I, et al. Among authors: zowall h. J Cardiopulm Rehabil. 2000 May-Jun;20(3):147-55. doi: 10.1097/00008483-200005000-00002. J Cardiopulm Rehabil. 2000. PMID: 10860196
The economic burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.
Grover SA, Coupal L, Zowall H, Rajan R, Trachtenberg J, Elhilali M, Chetner M, Goldenberg L. Grover SA, et al. Among authors: zowall h. CMAJ. 2000 Apr 4;162(7):987-92. CMAJ. 2000. PMID: 10763396 Free PMC article.
23 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback